Minocycline inhibits d-amphetamine-elicited action potential bursts in a central snail neuron

Neuroscience

Volumn 223, Issue , 2012, Pages 412-428

  Chen, Y H ^a   Lin, P L ^b   Wong, R W ^a   Wu, Y T ^a   Hsu, H Y ^a   Tsai, M C ^c   Lin, M J ^d   Hsu, Y C ^e   Lin, C H ^f  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e YUANPEI UNIVERSITY   (Taiwan)

^f KAINAN UNIVERSITY   (Taiwan)

Author keywords

Action potential; D amphetamine; Minocycline; Neuron

Indexed keywords

ADENYLATE CYCLASE; BUCLADESINE; CYCLIC AMP; DEXAMPHETAMINE; FORSKOLIN; MINOCYCLINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C; TETRYLAMMONIUM CHLORIDE;

ACTION POTENTIAL; ACTION POTENTIAL BURST; ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ELECTRIC CURRENT; NERVE CELL; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; SNAIL; STEADY STATE;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; BUCLADESINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTRIC STIMULATION; FORSKOLIN; GANGLIA, INVERTEBRATE; MINOCYCLINE; NEURONS; POTASSIUM CHANNEL BLOCKERS; SNAILS; TETRAETHYLAMMONIUM;

EID: 84866490855     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.06.046     Document Type: Article

References (66)

1. Barker J.L., Smith T.G. Peptide regulation of neuronal membrane properties. Brain Res 1976, 103:167-170.
2. + currents by forskolin is not mediated via cAMP in pleural sensory neurons of Aplysia. J Neurophysiol 1990, 64:1474-1483.
3. Bonelli R.M., Kapfhammer H.P. Why minocycline is helpful in Huntington's disease. J Psychopharmacol 2003, 17:461.
4. Bukanova J.V., Solntseva E.I., Skrebitsky V.G. Selective suppression of the slow-inactivating potassium currents by nootropics in molluscan neurons. Int J Neuropsychopharmacol 2002, 5:229-237.
5. + current. Neuroscience 2006, 138:257-280.
6. Chen Y.H., Tsai M.C. Bursting firing of action potential in central snail neuron elicited by d-amphetamine: role of the intracellular calcium ions. Comparative biochemistry and physiology. A. Comp Physiol 1996, 115:195-205.
7. Chen Y.H., Tsai M.C. Bursting firing of action potentials in central snail neurons elicited by d-amphetamine: role of cytoplasmic second messengers. Neurosci Res 1997, 27:295-304.
8. Chen Y.H., Tsai M.C. Action potential bursts in central snail neurons elicited by d-amphetamine: roles of ionic currents. Neuroscience 2000, 96:237-248.
9. Conn P.J., Strong J.A., Azhderian E.M., Nairn A.C., Greengard P., Kaczmarek L.K. Protein kinase inhibitors selectively block phorbol ester- or forskolin-induced changes in excitability of Aplysia neurons. J Neurosci 1989, 9:473-479.
10. Connors B.W., Gutnick M.J., Prince D.A. Electrophysiological properties of neocortical neurons in vitro. J Neurophysiol 1982, 48:1302-1320.
11. Defaux A., Zurich M.G., Honegger P., Monnet-Tschudi F. Minocycline promotes remyelination in aggregating rat brain cell cultures after interferon-gamma plus lipopolysaccharide-induced demyelination. Neuroscience 2011, 187:84-92.
12. Domercq M., Matute C. Neuroprotection by tetracyclines. Trends Pharmacol Sci 2004, 25:609-612.
13. Emaduddin M., Liu G.J., Takeuchi H., Munekata E. Multiple intracellular signal transduction pathways mediating inward current produced by the neuropeptide, achatin-I. Eur J Pharmacol 1996, 302:129-139.
14. Funase K. Oxytocin-induced sodium current is mediated by cAMP-dependent protein phosphorylation in an identified snail neuron. Brain Res 1990, 517:263-268.
15. Giorgi F.S., Pizzanelli C., Ferrucci M., Lazzeri G., Faetti M., Giusiani M., Pontarelli F., Busceti C.L., Murri L., Fornai F. Previous exposure to (+/-) 3,4-methylenedioxymethamphetamine produces long-lasting alteration in limbic brain excitability measured by electroencephalogram spectrum analysis, brain metabolism and seizure susceptibility. Neuroscience 2005, 136:43-53.
16. 2+ signalling in hippocampal neurons. Eur J Neurosci 2007, 26:2481-2495.
17. Gray C.M., McCormick D.A. Chattering cells: superficial pyramidal neurons contributing to the generation of synchronous oscillations in the visual cortex. Science 1996, 274:109-113.
18. Huerta P.T., Lisman J.E. Heightened synaptic plasticity of hippocampal CA1 neurons during a cholinergically induced rhythmic state. Nature 1993, 364:723-725.
19. Huerta P.T., Lisman J.E. Bidirectional synaptic plasticity induced by a single burst during cholinergic theta oscillation in CA1 in vitro. Neuron 1995, 15:1053-1063.
20. Ichinose M., McAdoo D.J. The voltage-dependent, slow inward current induced by the neuropeptide FMRFamide in Aplysia neuron R14. J Neurosci 1988, 8:3891-3900.
21. Jefferys J.G. Experimental neurobiology of epilepsies. Curr Opin Neurol 1994, 7:113-122.
22. Jefferys J.G. Nonsynaptic modulation of neuronal activity in the brain: electric currents and extracellular ions. Physiol Rev 1995, 75:689-723.
23. Kandel E.R., Spencer W.A. Electrophysiology of hippocampal neurons. After-potentials and repetitive firing II. J Neurophysiol 1961, 24:243-259.
24. Khabour O., Levenson J., Lyons L.C., Kategaya L.S., Chin J., Byrne J.H., Eskin A. Coregulation of glutamate uptake and long-term sensitization in Aplysia. J Neurosci 2004, 24:8829-8837.
25. Kish S.J. Pharmacologic mechanisms of crystal meth. CMAJ 2008, 178:1679-1682.
26. Kiss T., Hiripi L., Papp N., Elekes K. Dopamine and serotonin receptors mediating contractions of the snail, Helix pomatia, salivary duct. Neuroscience 2003, 116:775-790.
27. Kofman O., Klein E., Newman M., Hamburger R., Kimchi O., Nir T., Shimon H., Belmaker R.H. Inhibition by antibiotic tetracyclines of rat cortical noradrenergic adenylate cyclase and amphetamine-induced hyperactivity. Pharmacol Biochem Behav 1990, 37:417-424.
28. Lancaster B., Nicoll R.A. Properties of two calcium-activated hyperpolarizations in rat hippocampal neurones. J Physiol 1987, 389:187-203.
29. Lancaster B., Nicoll R.A., Perkel D.J. Calcium activates two types of potassium channels in rat hippocampal neurons in culture. J Neurosci 1991, 11:23-30.
30. Lee C.H., Liou H.H., Lu K.L., Shen Y.C., Tsai M.C. D-Amphetamine inhibits inwardly rectifying potassium channels in Xenopus oocytes expression system. Neurotoxicology 2008, 29:638-646.
31. Lin C.H., Tsai M.C. Effects of procaine on a central neuron of the snail, Achatina fulica Ferussac. Life Sci 2005, 76:1641-1666.
32. Lin C.H., Tsai M.C. The modulation effects of d-amphetamine and procaine on the spontaneously generated action potentials in the central neuron of snail, Achatina fulica Ferussac. Comp Biochem Physiol C Toxicol Pharmacol 2005, 141:58-68.
33. Lin C.H., Wu C.L., Lin M.S., Liu M.C., Lin P.J., Tsai M.C. Effects of 2,3-butanedione monoxime on induction of action potential bursts in central snail neurons: direct and indirect modulations of ionic currents. Pharmacology 2005, 73:57-69.
34. Lin P.L., Tsai M.C., Lu G.L., Lu D.Y., Chuang C.M., Yang H.Y., Huang S.S., Chen Y.H. Ecstasy and methamphetamine elicit action potential bursts via different mechanisms in a central snail neuron. Neurotoxicology 2010, 31:26-41.
35. Lisman J.E. Bursts as a unit of neural information: making unreliable synapses reliable. Trends Neurosci 1997, 20:38-43.
36. Llinas R., Jahnsen H. Electrophysiology of mammalian thalamic neurones in vitro. Nature 1982, 297:406-408.
37. Lovell P.V., McCobb D.P. Pituitary control of BK potassium channel function and intrinsic firing properties of adrenal chromaffin cells. J Neurosci 2001, 21:3429-3442.
38. 2+-sensitive outward current in a vertebrate neurone. Nature 1982, 300:185-188.
39. Maxwell J.C., Rutkowski B.A. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007. Drug Alcohol Rev 2008, 27:229-235.
40. Metharom P., Ellem K.A., Schmidt C., Wei M.Q. Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma. Hum Gene Ther 2001, 12:2203-2213.
41. Mizoguchi H., Takuma K., Fukakusa A., Ito Y., Nakatani A., Ibi D., Kim H.C., Yamada K. Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice. Psychopharmacology (Berl) 2008, 196:233-241.
42. Onozuka M., Imai S., Furuichi H., Ozono S. A specific 70K protein found in epileptic rat cortex: induction of bursting activity and negative resistance by its intracellular application in Euhadra neurons. J Neurobiol 1991, 22:287-297.
43. Onozuka M., Kubo K.Y., Ozono S. The molecular mechanism underlying pentylenetetrazole-induced bursting activity in Euhadra neurons: involvement of protein phosphorylation. Comp Biochem Physiol C 1991, 100:423-432.
44. Orio L., Llopis N., Torres E., Izco M., O'Shea E., Colado M.I. A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons. Neurotox Res 2010, 18:187-199.
45. Premkumar L.S., Ahern G.P. Blockade of a resting potassium channel and modulation of synaptic transmission by ecstasy in the hippocampus. J Pharmacol Exp Ther 1995, 274:718-722.
46. Ravina B.M., Fagan S.C., Hart R.G., Hovinga C.A., Murphy D.D., Dawson T.M., Marler J.R. Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment. Neurology 2003, 60:1234-1240.
47. Smith T.G., Barker J.L., Gainer H. Requirements for bursting pacemaker potential activity in molluscan neurones. Nature 1975, 253:450-452.
48. Sofuoglu M., Mooney M., Kosten T., Waters A., Hashimoto K. Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans. Psychopharmacology (Berl) 2011, 213:61-68.
49. Staras K., Gyori J., Kemenes G. Voltage-gated ionic currents in an identified modulatory cell type controlling molluscan feeding. Eur J Neurosci 2002, 15:109-119.
50. Sugaya E., Furuichi H., Takagi T., Kajiwara K., Komatsubara J. Intracellular calcium concentration during pentylenetetrazol-induced bursting activity in snail neurons. Brain Res 1987, 416:183-186.
51. Szymusiak R., Shouse M.N., McGinty D. Brainstem stimulation during sleep evokes abnormal rhythmic activity in thalamic neurons in feline penicillin epilepsy. Brain Res 1996, 713:253-260.
52. Tanaka M., Watanabe Y., Yoshimoto K. Regulation of relaxin 3 gene expression via cAMP-PKA in a neuroblastoma cell line. J Neurosci Res 2009, 87:820-829.
53. Thompson S.H. Three pharmacologically distinct potassium channels in molluscan neurones. J Physiol 1977, 265:465-488.
54. Tsai M.C., Chen Y.H. Bursting firing of action potentials in central snail neurons elicited by d-amphetamine: role of the electrogenic sodium pump. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1995, 111:131-141.
55. Tsai M.C., Chen Y.H. (+/-)3,4-Methylenedioxyamphetamine elicits action potential bursts in a central snail neuron. Exp Neurol 2007, 203:423-444.
56. Tsai M.C., Chen Y.H., Huang S.S. Amphetamine elicited potential changes in vertebrate and invertebrate central neurons. Acta Biol Hung 2000, 51:275-286.
57. Ure A., Altrup U. Block of spontaneous termination of paroxysmal depolarizations by forskolin (buccal ganglia, Helix pomatia). Neurosci Lett 2006, 392:10-15.
58. Wang X., Zhu S., Drozda M., Zhang W., Stavrovskaya I.G., Cattaneo E., Ferrante R.J., Kristal B.S., Friedlander R.M. Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proc Natl Acad Sci USA 2003, 100:10483-10487.
59. Wilson W.A., Wachtel H. Prolonged inhibition in burst firing neurons: synaptic inactivation of the slow regenerative inward current. Science 1978, 202:772-775.
60. Wixey J.A., Reinebrant H.E., Spencer S.J., Buller K.M. Efficacy of post-insult minocycline administration to alter long-term hypoxia-ischemia-induced damage to the serotonergic system in the immature rat brain. Neuroscience 2011, 182:184-192.
61. Wu D.C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.K., Ischiropoulos H., Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 2002, 22:1763-1771.
62. Yong V.W., Wells J., Giuliani F., Casha S., Power C., Metz L.M. The promise of minocycline in neurology. Lancet Neurol 2004, 3:744-751.
63. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 1998, 95:15769-15774.
64. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 1999, 96:13496-13500.
65. Zhang L., Shirayama Y., Shimizu E., Iyo M., Hashimoto K. Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain. Eur J Pharmacol 2006, 544:1-9.
66. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu D.C., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., Friedlander R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002, 417:74-78.